Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-25 @ 7:12 PM
Study NCT ID:
NCT03447132
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2018-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Sponsor:
International Cancer Research Group, United Arab Emirates
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-11
First Submit QC Date:
None
Study First Post Date:
2018-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-08
Last Update Post Date:
2023-03-10
Last Update Post Date Type:
ACTUAL